[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[argenx SE](/topic/$argx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$argx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$argx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +15%  
**6 Months**: XX% +4%  
**1 Year**: XX% +27%  
**1-Year High**: XXX% on 2024-10-28  
**1-Year Low**: XX% on 2025-01-27  

**Most Supportive Themes**
- **Positive Analyst Ratings and Price Target Increases:** (40%) Several analysts have upgraded argenx SE with increased price targets, indicating positive sentiment and potential for future growth.
- **Strong Growth in R&D and Promising Pipeline:** (35%) argenx SE is showing robust growth driven by Vyvgart and substantial R&D investments, suggesting long-term opportunity in the biotech sector.
- **Positive Trial Results and FDA Approval Expectations:** (20%) Promising updates on phase X trials have exceeded expectations, potentially speeding up FDA approval processes.
  
**Most Critical Themes**
- **Deutsche Bank Downgrade:** (5%)  Deutsche Bank downgraded argenx SE to 'hold' citing a recent stock surge and valuation concerns.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXX   | XX% | XXX      | X% |
| Reddit  | X        | X%  | X       | X%  | X        | X% |
| TikTok  | X        | X%  | X       | X%  | X        | X% |
| YouTube | XXX      | X%  | XXX     | X%  | X        | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXX   | XX% | XXX      | X% |